Cargando…

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis

Diagnosis of minimal hepatic encephalopathy (MHE) requires psychometric testing, which is time‐consuming and often neglected in clinical practice. Elevated Interleukin‐6 (IL‐6) serum levels have been linked to MHE. The aim of this study was to investigate the usefulness of IL‐6 as a biomarker in a s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gairing, Simon Johannes, Anders, Julian, Kaps, Leonard, Nagel, Michael, Michel, Maurice, Kremer, Wolfgang Maximilian, Hilscher, Max, Galle, Peter Robert, Schattenberg, Jörn M., Wörns, Marcus‐Alexander, Labenz, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035565/ https://www.ncbi.nlm.nih.gov/pubmed/35032100 http://dx.doi.org/10.1002/hep4.1883

Ejemplares similares

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2022)

Risk factors for poorer health literacy in patients with liver cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2021)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
por: Michel, Maurice, et al.
Publicado: (2021)

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
por: Kremer, Wolfgang M., et al.
Publicado: (2020)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2023)

Development and evaluation of a virtual reality driving test for patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
por: Labenz, Christian, et al.
Publicado: (2020)

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
por: Nagel, Michael, et al.
Publicado: (2023)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
por: Kaps, Leonard, et al.
Publicado: (2022)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
por: Nagel, Michael, et al.
Publicado: (2022)

Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Health-related quality of life in patients with autoimmune hepatitis
por: Michel, Maurice, et al.
Publicado: (2021)

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
por: Nagel, Michael, et al.
Publicado: (2020)

Metabolic dysfunction-associated fatty liver disease in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2023)

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
por: Nagel, Michael, et al.
Publicado: (2022)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Diabetes mellitus – risk factor and potential future target for hepatic encephalopathy in patients with liver cirrhosis?
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Portal vein thrombosis is associated with an increased risk of bone fractures
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
por: Labenz, Christian, et al.
Publicado: (2020)

Proton pump inhibitor use is associated with a variety of infections in patients with liver cirrhosis
por: Labenz, Christian, et al.
Publicado: (2020)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
por: Labenz, Christian, et al.
Publicado: (2020)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
por: Kaps, L., et al.
Publicado: (2021)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany
por: Tilch, Marie-Kristin, et al.
Publicado: (2021)

Predictors of Minimal Hepatic Encephalopathy in Patients with Cirrhosis
por: Sharma, Praveen, et al.
Publicado: (2010)

The unmet need of personalized HCC screening—Lessons learned from the Swedish nationwide registries
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol
por: Labenz, Christian, et al.
Publicado: (2019)

Detection of Minimal Hepatic Encephalopathy in Iranian Patients with Cirrhosis
por: Khodadoostan, Mahsa, et al.
Publicado: (2018)

(13)C-Methacetin Breath Test Predicts Survival in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Modulation of the Metabiome by Rifaximin in Patients with Cirrhosis and Minimal Hepatic Encephalopathy
por: Bajaj, Jasmohan S., et al.
Publicado: (2013)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qrorbosdq741kdnol73l0f399j